Kaysia Ludford, M.D.
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2014 | Yale University School of Medicine, New Haven, CT, USA, MD, Medicine |
| 2009 | University of Michigan, Ann Arbor, MI, USA, MS, Chemistry |
| 2007 | Vassar College, Poughkeepsie, NY, USA, BA, Chemistry |
Postgraduate Training
| 2017-2020 | Clinical Fellowship, Medical Oncology/Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2014-2017 | Clinical Residency, Internal Medicine, Brigham and Women’s Hospital, Boston, MA |
Board Certifications
| 2020 | American Board of Internal Medicine, Medical Oncology |
| 2020 | American Board of Internal Medicine, Hematology |
| 2017 | Internal Medicine |
| 2017 | American Board of Internal Medicine (ABIM) |
Experience & Service
Other Appointments/Responsibilities
Hematology/Oncology Fellowship Education Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020
Institutional Committee Activities
Guest Speaker, Hightower Medical Science Academy, 2023 - 2023
Guest Presenter, Combined Modality of Cancer Tumor Board, 2022 - Present
Faculty Liaison, General Oncology (LBJ) to Harris Health Department of Radiation Oncology, 2022 - Present
Member, Division of Cancer Medicine Division Chief Advisory Committee, 2022 - 2022
Member, Hematology Oncology Fellowship Interview Panel, 2021 - Present
Director, LBJ Faculty Consensus Workshop, 2021 - Present
Reviewer, Committee on Cancer Registry Quality Control, 2021 - Present
Co-Chair, Colorectal Conference, 2021 - Present
Co-chair, Breast Multidisciplinary Conference, 2021 - Present
Committee Member, Faculty Awards Review, 2020 - Present
Co-chair, Gastrointestinal Tumor Board, Lyndon B Johnson Hospital, 2020 - Present
Member, Education Committee, 2019 - 2020
Member, Global Oncology Interest Group, 2019 - 2020
Member, Health Disparities, 2018 - Present
Member, Diversity and Inclusion Committee, 2016 - 2017
Member, Wellness Committee, 2016 - 2017
Member, Partners in Health, 2016 - Present
Member, Student National Medical Association, 2011 - 2012
Member, Yale Health Professionals Christian Fellowship, 2010 - 2014
Member, Haven Free Clinic, 2010 - 2011
Honors & Awards
| 2022 | Special Projects Grant within the Alliance for Clinical Trials in Oncology Cancer Control Program |
| 2022 | Career Enhancement Program Award, MD Anderson Cancer Center |
| 2022 | Prioritizing Research Innovation & Mentoring Excellence |
| 2020 | AACR Gertrude B. Elion Cancer Research Award |
| 2016 | Partners’ Center of Expertise Global and Humanitarian Health Award |
| 2013 | Yale University Lowe Funds Award for International Conference Travel |
| 2011 | Yale University Downs International Health Student Travel Fellowship |
| 2011 | The Infectious Disease Society of America Education and Research Foundation National Medical Scholars Award, |
| 2010 | Vassar College HB and JS Nicholas Fellowship |
| 2008 | University of Michigan Rackham International Graduate Students Award |
| 2007 | Elected Phi Beta Kappa Academic Honor Society |
| 2007 | Elected Sigma Xi Scientific Research Society |
| 2007 | Olive Lammert Prize for Excellence in Chemistry |
| 2007 | American Chemical Society Award in Analytic Chemistry |
| 2004 | Howard Hughes Medical Institute Scholar |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Ludford K, Ho WJ, Thomas JV, Raghav KPS, Murphy MB, Fleming ND, Lee MS, Smaglo BG, You YN, Tillman MM, Kamiya-Matsuoka C, Thirumurthi S, Messick C, Johnson B, Vilar E, Dasari A, Shin S, Hernandez A, Yuan X, Yang H, Foo WC, Qiao W, Maru D, Kopetz S, Overman MJ. Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors. J Clin Oncol:JCO2201351. e-Pub 2023. PMID: 36623241.
- Ludford K, Cohen R, Svrcek M, Foo WC, Colle R, Parc Y, Thomas JV, Morris VK, Kopetz S, Chang GJ, Overman M, Andre T. Pathological tumor response following immune checkpoint blockade for deficient mismatch repair advanced colorectal cancer. J Natl Cancer Inst 113(2):208-211, 2021. e-Pub 2020. PMID: 32294214.
- Saberian C, Abdel-Wahab N, Abudayyeh A, Rafei H, Joseph J, Rondon G, Whited L, Gruschkus S, Fa'ak F, Daher M, Knape C, Safa H, Shoukier M, Suarez-Almazor ME, Marcotulli M, Ludford K, Gulbis AM, Konopleva M, Ohanian M, Ravandi F, Garcia-Manero G, Oran B, Popat UR, Mehta R, Alousi AM, Daver N, Champlin R, Diab A, Al-Atrash G. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. J Immunother Cancer 9(2), 2021. PMID: 33637601.
- Ludford KT, Vagenas P, Lama JR, Peinado J, Gonzalez P, et al. Screening for drug and alcohol use disorders and their association with HIV-related sexual risk behaviors among men who have sex with men in Peru. PLoS One, 2013.
- Vagenas P, Ludford KT, Gonzalez P, et al. Being unaware of being HIV-infected is associated with alcohol use disorders and high risk sexual behaviors among men who have sex with men in Peru. AIDS and Behavior:1-8, 2013.
- MacMillan SN, Ludford KT, Tanski JM. Synthesis and optical activity analysis of chiral titanium (IV) sec-butoxide and its group IV analogues. Tetrahedron: Asymmetry 19(5):543-458, 2008.